Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S3QX
|
|||
Drug Name |
PMID27977313-Compound-30
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H14O6
|
|||
Canonical SMILES |
CC1=CC2=C(C(=O)C=CC2=O)C(=C1C3=C4C(=O)C=CC(=O)C4=C(C=C3C)O)O
|
|||
InChI |
1S/C22H14O6/c1-9-7-11-12(23)3-4-13(24)19(11)22(28)18(9)17-10(2)8-16(27)20-14(25)5-6-15(26)21(17)20/h3-8,27-28H,1-2H3
|
|||
InChIKey |
OEEOHKZVBKYMBA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 20175-84-2
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:6002
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cytoplasmic thioredoxin reductase (TXNRD1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Cytoplasmic thioredoxin reductase (TXNRD1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Thioredoxin reductase inhibitors: a patent review.Expert Opin Ther Pat. 2017 May;27(5):547-556. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.